Latest News

Reviewing an array of study presentations from the recent RSNA meeting, this author discusses insights from emerging research, ranging from the use of large language models (LLMs) in radiology reports to the potential impact of LLM assistance in differential diagnosis for brain MRIs.

In a recent interview at the RSNA conference, Rajesh Bhayana, M.D., discussed current research findings on the use of large language models (LLMs) in radiology and emerging LLMs that may have an impact.

Providing automated analysis of non-contrast head CT scans, the AI-enabled Scaida BrainCT-ICH software offers a specificity of 88.7 percent for intracranial hemorrhage detection with less than six seconds of processing time.

Don’t overreact, keep your options open and develop off-ramps so you’re prepared regardless of the changes to come with AI.

Catch up on the top radiology content of the past week.

In a recent interview at the RSNA conference, Roland Rott shared his perspective on the planned acquisition of Intelerad by GE HealthCare along with insights on key synergies and future directions.

In a recent interview at the RSNA conference, Manisha Bahl, M.D., discussed new research examining the use of slab reconstruction technology with digital breast tomosynthesis (DBT), and its potential in reducing interpretation time and imaging volume.

In a recent interview at the RSNA conference, Talissa Altes, M.D., and Konstanze Diefenbach, M.D., discussed the potential utility and recent research findings on the use of the MRI contrast agent gadoquatrane for pediatric patients.

For men with a 1 μg/m3 increase in ten-year exposure to fine particulate matter, a common air pollutant, there was a 47 increased likelihood of moving to a higher CAD-RADS stenosis category, according to new coronary CT angiography research presented at the Radiological Society of North America (RSNA) conference.

Absent flow to perforator vessels in the face occurred in over 40 percent of women who had cosmetic fillers, according to new vascular ultrasound research presented at the RSNA conference.

Preliminary research has shown that the Vanquish Water Vapor Ablation System eliminated MRI-visible intermediate-risk PCa in over 90 percent of patients.

The Resona A20 device reportedly provides advances in imaging and AI automation along with an intuitive ergonomic design for ease of use.

In a recent interview at the RSNA conference, Constance Lehman, M.D., Ph.D., discussed new research, which compared image-based AI for mammography versus breast density assessment in evaluating breast cancer risk.